Topical dermatologic acne treatment cream composition and method of manufacture

Abstract

The present invention provides a topical cream composition for the treatment of acne vulgaris and the method of manufacturing thereof. The topical dermatologic acne treatment cream functions through a two-stage process: the clearing the acne currently present on the skin; and reducing the potential reoccurrence of additional acne. The clearing of the presenting acne is accomplished through the use of an acne bactericidal. The reducing the potential reoccurrence of additional acne is accomplished through a skin revitalizing compound that returns the skin to its natural homeostasis thereby encouraging the regrowth of natural, non-acne vulgaris causing, bacterial flora and the microbiome of the skin. The present invention also provides for a method of manufacture the Topical Dermatologic Acne Treatment Cream through two-stage process wherein the bactericidal is added to the skin revitalizing compound. The skin revitalizing compound can be used as a secondary element to various skin conditions or on its own to maintain the general health and skin condition.

1 . A topical dermatologic acne treatment cream comprising:
 a) a bactericidal component; and,   b) a skin revitalizing complex;   wherein the bactericidal component clears the acne causing bacteria, and the skin revitalizing complex revitalizes and conditions the skin and aids in the return of the natural skin flora and microbiome to prevent subsequent outbreaks.   
     
     
         2 . The cream of  claim 1  wherein the skin revitalizing complex comprises:
 a) niacinamide; 
 b) retinol; 
 c) bakuchiol; 
 d) green coffee bean extract; 
 e) green tea extract; 
 f) epilobium fleischeri extract; 
 g) citric acid; 
 h) dimethicone; and, 
 i) pentaerythrityl tetracaprylate; 
 
       wherein the elements of the skin revitalizing complex restores the natural elasticity and oil production of the skin, decrease sebum production, and provide the necessary conditioning of the skin to provide for the natural skin flora and microbiome to repopulate and flourish on the surface of the skin. 
     
     
         3 . The cream of  claim 1  wherein said bactericidal comprises benzoyl peroxide. 
     
     
         4 . The cream of  claim 1 , wherein said bactericidal component comprises clindamycin. 
     
     
         5 . The cream of  claim 1 , wherein said bactericidal component comprises erythromycin. 
     
     
         6 . The cream of  claim 1 , wherein said bactericidal component comprises minocycline 
     
     
         7 . The cream of  claim 1 , wherein said bactericidal component comprises dapsone. 
     
     
         8 . The cream of  claim 1 , wherein said bactericidal component comprises sulfur. 
     
     
         9 . The cream of  claim 1 , wherein said bactericidal component comprises tea tree oil. 
     
     
         10 . The cream of  claim 1 , wherein said bactericidal component comprises zinc salts. 
     
     
         11 . The cream of  claim 1 , wherein said bactericidal component comprises Hydroxytyrosol. 
     
     
         12 . A method of manufacture of the topical dermatologic acne treatment comprising:
 a. blending of a skin revitalizing complex in large batch;   b. splitting the skin revitalizing complex batch is into numerous containers; and,   c. adding a different active element for a different indication into the various containers;   
       wherein the topical dermatologic acne treatment cream is made through the use of a heated oil in water blended emulsion and elements are added gradually while temperature slowly decreases. 
     
     
         13 . A topical dermatologic acne treatment cream comprising of:
 a) micro encapsulated benzoyl peroxide at 2.5% w/w;   b) niacinamide at 2.0% w/w;   c) retinol at 0.5% w/w;   d) bakuchiol at 0.5% w/w;   e) green coffee bean extract at 0.5% w/w;   f) green tea extract at 0.5% w/w;   g) epilobium fleischeri extract at 0.5% w/w;   h) citric acid at 0.1% w/w;   i) dimethicone at 1.0% w/w; and,   j) pentaerythrityl tetracaprylate at 2.0% w/w.   
     
     
         14 . The cream of  claim 13  further comprising neem oil. 
     
     
         15 . (canceled) 
     
     
         16 . The cream of  claim 13  wherein said cream is used for the treatment of actinic keratosis. 
     
     
         17 . The cream of  claim 1  wherein said cream is used for the treatment of actinic keratosis. 
     
     
         18 . The method of  claim 12  wherein said topical dermatologic acne treatment cream is adapted to treat actinic keratosis.